KURA: Kura Oncology, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Kura Oncology, Inc.

NASDAQ:KURA

SummaryFactSheetFinancial
Price
$9.04
Loss Chance
58.3%
0.68JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Biotechnology
164 / 278
Health Care
524 / 714
United States
?
3,554 / 4,217
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.31
39.65%
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.31
39.65%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.27
42.83%
Exelixis
NASDAQ:EXEL
6.93
$50.28
33.50%
Fabien Corp.
NASDAQ:FBIO
1.90
$0.13
100.00%
Jitta Factors
Growth Opportunity (6)
Recent Business Performance (20)
Financial Strength (36)
Return to Shareholders (0)
Competitive Advantage (16)
Jitta Signs
Cash Conversion CycleLess than 30 days
Operating MarginDeclined
Recent Business PerformanceEarning decline 45.45% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.68
100.00%
2.22
137.59%
3.06
159.47%
Biotechnology
5.68
39.65%
5.68
39.65%
6.36
42.83%
COMPANY DESCRIPTION
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
kuraoncology.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.